The 46,000 Shares in Imperva Inc. (IMPV) Acquired by Capital Fund Management S.A.

The 46,000 Shares in Imperva Inc. (IMPV) Acquired by Capital Fund Management S.A.

Capital Fund Management S.A. bought a new position in Imperva Inc. (NYSE:IMPV) during the third quarter, Holdings Channel reports. The institutional investor bought 46,000 shares of the company’s stock, valued at approximately $2,471,000.

A number of other hedge funds have also recently added to or reduced their stakes in IMPV. Fisher Asset Management LLC raised its position in Imperva by 24.1% in the third quarter. Fisher Asset Management LLC now owns 153,236 shares of the company’s stock worth $8,230,000 after buying an additional 29,807 shares during the last quarter. Penserra Capital Management LLC raised its position in Imperva by 28.0% in the second quarter. Penserra Capital Management LLC now owns 775,782 shares of the company’s stock worth $33,366,000 after buying an additional 169,788 shares during the last quarter. Artemis Investment Management LLP bought a new position in Imperva during the second quarter worth approximately $398,000. State Board of Administration of Florida Retirement System raised its position in Imperva by 1.6% in the second quarter. State Board of Administration of Florida Retirement System now owns 17,640 shares of the company’s stock worth $759,000 after buying an additional 277 shares during the last quarter. Finally, Elk Creek Partners LLC raised its position in Imperva by 124.9% in the second quarter. Elk Creek Partners LLC now owns 343,824 shares of the company’s stock worth $8,652,000 after buying an additional 190,955 shares during the last quarter. 92.72% of the stock is owned by institutional investors and hedge funds.

Imperva Inc. (NYSE:IMPV) traded down 0.12% on Thursday, hitting $40.30. The stock had a trading volume of 405,923 shares. The firm’s market cap is $1.32 billion. The company’s 50 day moving average price is $38.30 and its 200 day moving average price is $43.21. Imperva Inc. has a 52-week low of $31.11 and a 52-week high of $57.93.

Imperva (NYSE:IMPV) last issued its earnings results on Thursday, November 3rd. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.24. The company earned $68.40 million during the quarter, compared to the consensus estimate of $63.10 million. Imperva had a negative net margin of 25.60% and a negative return on equity of 28.37%. Imperva’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.19 EPS. Analysts expect that Imperva Inc. will post ($0.37) EPS for the current year.

A number of equities analysts have recently commented on the company. Zacks Investment Research raised Imperva from a “hold” rating to a “strong-buy” rating and set a $45.00 price target for the company in a report on Wednesday, November 9th. DA Davidson reaffirmed a “buy” rating and issued a $53.00 price target (down from $57.00) on shares of Imperva in a report on Wednesday, December 21st. Needham & Company LLC raised Imperva from a “hold” rating to a “buy” rating and cut their price target for the stock from $64.00 to $43.00 in a report on Friday, November 4th. Evercore ISI raised Imperva from a “hold” rating to a “buy” rating in a report on Friday, November 4th. Finally, Imperial Capital reaffirmed an “outperform” rating and issued a $50.00 price target on shares of Imperva in a report on Wednesday, November 9th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $49.50.

In other Imperva news, SVP Mark E. Kraynak sold 3,332 shares of the stock in a transaction dated Wednesday, November 16th. The shares were sold at an average price of $40.16, for a total transaction of $133,813.12. Following the completion of the transaction, the senior vice president now owns 448 shares of the company’s stock, valued at approximately $17,991.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Amichai Shulman sold 3,085 shares of the stock in a transaction dated Wednesday, December 21st. The shares were sold at an average price of $40.00, for a total transaction of $123,400.00. Following the transaction, the insider now directly owns 91,830 shares of the company’s stock, valued at approximately $3,673,200. The disclosure for this sale can be found here. Insiders sold a total of 12,587 shares of company stock valued at $506,173 in the last ninety days. 2.20% of the stock is currently owned by insiders.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.

Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva Inc. (NYSE:IMPV).

Related posts

Leave a Comment